Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Definium Therapeutics, Inc. DFTX

Set alert

Price alert · DFTX

All alert types
32.47 USD 0.00 0.00%

At close

32.90 +0.43 +1.32%

Pre-market · Nov 3, 9:16 AM ET

Bid
32.46 × 4
Ask
32.47 × 1

Day range unavailable

10.47 52-week range 49.70
YTD
+142.49%
1 year
+164.20%
Open
—
Prev close
32.47
Mkt cap
4.36B
Vol
0
Avg vol
2.18M
EPS
-3.43
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-16.73
Beta
2.21
Short ratio
4.32
Inst. own
96.39%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
37.77
200-d avg
29.60
1y target
72.56

1D chart

Chart tools
Interval
1m5m15m30m

Signals (88)
NameTimeAgo
RSI: Oversold3:57 PM17 hours ago
MACD: Sell Signal3:53 PM17 hours ago
SMA: Bearish3:50 PM17 hours ago
SMA: Bullish3:46 PM17 hours ago
MACD: Buy Signal3:43 PM17 hours ago
SMA: Bearish3:28 PM17 hours ago
SMA: Bearish3:22 PM17 hours ago
SMA: Bullish3:13 PM18 hours ago
SMA: Bearish3:10 PM18 hours ago
MACD: Sell Signal3:07 PM18 hours ago
RSI: Overbought2:56 PM18 hours ago
SMA: Bullish2:52 PM18 hours ago
SMA: Bearish2:48 PM18 hours ago
SMA: Bullish2:45 PM18 hours ago
SMA: Bullish2:44 PM18 hours ago
MACD: Buy Signal2:44 PM18 hours ago
MACD: Sell Signal2:37 PM18 hours ago
SMA: Bearish2:35 PM18 hours ago
SMA: Bearish2:35 PM18 hours ago
SMA: Bullish2:33 PM18 hours ago

Newest 20 of 88.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 72.56 +123.5% upside
Target (low)
55.00
Target (mean)
72.56
Target (high)
91.00
Ratings (0m) 19 19 buy · 0 hold · 0 sell
  • Strong buy5
  • Buy14
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 19
  • 1 month ago 18
  • 2 months ago 18

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DFTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.56065-0.70 – -0.45-0.78+28.1%00.0%14
Next quarter-0.53494-0.74 – -0.42-0.50-7.0%00.0%14
Current year-3.19-3.59 – -2.93-2.06-54.7%00.0%15
Next year-1.94-4.16 – 0.05-3.19+39.1%29.32M0.0%14

Upgrades and downgrades

The latest rating changes

DFTX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026JP MorganInitiated—Overweight
Sep 15, 2026Canaccord GenuityMaintainedBuyBuy
Sep 15, 2026BairdMaintainedOutperformOutperform
Sep 14, 2026HC Wainwright & Co.ReiteratedBuyBuy
Sep 14, 2026NeedhamReiteratedBuyBuy
Sep 11, 2026RBC CapitalReiteratedOutperformOutperform
Aug 18, 2026B of A SecuritiesInitiated—Buy
Aug 14, 2026Maxim GroupMaintainedBuyBuy
Aug 13, 2026Jones TradingMaintainedBuyBuy
Aug 13, 2026Canaccord GenuityMaintainedBuyBuy
Aug 13, 2026RBC CapitalMaintainedOutperformOutperform
Aug 13, 2026Wells FargoMaintainedOverweightOverweight
Aug 13, 2026BairdMaintainedOutperformOutperform
Aug 12, 2026NeedhamMaintainedBuyBuy
Aug 7, 2026Piper SandlerReiteratedOverweightOverweight
Jul 27, 2026Wells FargoInitiated—Overweight
Jul 24, 2026Piper SandlerReiteratedOverweightOverweight
Jul 8, 2026StifelMaintainedBuyBuy
Jun 30, 2026Canaccord GenuityMaintainedBuyBuy
Jun 24, 2026Jones TradingMaintainedBuyBuy
Jun 23, 2026BairdMaintainedOutperformOutperform
Jun 23, 2026NeedhamMaintainedBuyBuy
Jun 22, 2026Leerink PartnersMaintainedOutperformOutperform
Jun 22, 2026OppenheimerMaintainedOutperformOutperform
Jun 16, 2026Canaccord GenuityMaintainedBuyBuy
May 8, 2026Piper SandlerMaintainedOverweightOverweight
Apr 22, 2026Leerink PartnersMaintainedOutperformOutperform
Apr 17, 2026StifelInitiated—Buy
Apr 16, 2026Canaccord GenuityMaintainedBuyBuy
Apr 10, 2026Piper SandlerInitiated—Overweight